MTOR and melanoma: Sinnberg et al. [43] studied combinations of the PI3K inhibitor LY294002 or the mTOR inhibitor rapamycin with the chemotherapeutics cisplatin or temozolomide, finding that these combinations significantly induced apoptosis of melanoma cells and completely suppressed invasive tumor growth of melanoma cells.